跳至主要内容
临床试验/NCT02851355
NCT02851355已完成不适用

Follow-up Survey of Patients Who Were Treated for Medulloblastoma or Primitive Neuroectodermal Tumors of the Central Nervous in Norway

Oslo University Hospital1 个研究点 分布在 1 个国家目标入组 2 人开始时间: 2016年9月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
2
试验地点
1
主要终点
SF 36 for those older than 18 years

研究概览

简要总结

Clinical follow-up survey of the Norwegian material of paediatric patients who received therapy for medulloblastoma and CNS-PNET from 1974 - 2013 with a focus on quality of life, education, work, family and children, delayed effects of tumour disease and treatment, endocrine evaluation, existence of auditory neuropathy, and neuropsychological testing.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
5 Years 至 51 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Whose who has been treated for medulloblastoma og CNS-PNET between 1974 and 2013

排除标准

  • Other brain tumours

结局指标

主要结局

SF 36 for those older than 18 years

时间窗: 1 year

Questionnaire

PedsQL for those younger than 18 years

时间窗: 1 year

Questionnaire

次要结局

未报告次要终点

研究者

发起方
Oslo University Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Einar Stensvold

M.D

Oslo University Hospital

研究点 (1)

Loading locations...

相似试验